Frontlight ResearchEarly access
Trial site
University Hospital St. Anna
- 3running trials
- 9closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- High blood pressure3 trials
- Stroke3 trials
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Heart failure2 trials
- Pulmonary arterial hypertension2 trials
- Chronic kidney disease1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Status
- Completed9 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Actelion1 trial
- Amgen1 trial
- Anthos Therapeutics, Inc.1 trial
- AstraZeneca1 trial
- and 5 more
Running trials
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026